The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci

By Toropainen M.   Kayhty H.   Saarinen L.   Rosenqvist E.   Hoiby E.A.   Wedege E.   Michaelsen T.   Makela P.H.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2677-2689

Elsevier

Access to resources Recommend Favorite

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile

By Boslego J.   Garcia J.   Cruz C.   Zollinger W.   Brandt B.   Ruiz S.   Martinez M.   Arthur J.   Underwood P.   Silva W.   Moran E.   Hankins W.   Gilly J.   Mays J.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 821-829

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers

By Drabick J.J.   Brandt B.L.   Moran E.E.   Saunders N.B.   Shoemaker D.R.   Zollinger W.D.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 160-172

Elsevier

Access to resources Recommend Favorite

Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease

By Aase A.   Naess L.M.   Sandin R.H.   Herstad T.K.   Oftung F.   Holst J.   Haugen I.L.   Hoiby E.A.   Michaelsen T.E.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2051-2060

Elsevier

Access to resources Recommend Favorite

Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys

By Rouppe van der Voort E.   Schuller M.   Holst J.   de Vries P.   van der Ley P.   van den Dobbelsteen G.   Poolman J.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1334-1343

Elsevier

Access to resources Recommend Favorite